ACTU vs VRTX: Which Stock is Better?
Side-by-side comparison of Actuate Therapeutics, Inc. Common stock and Vertex Pharmaceuticals Inc in 2026
ACTU
Actuate Therapeutics, Inc. Common stock
—
VRTX
Vertex Pharmaceuticals Inc
$485.65
Key Metrics Comparison
| Metric | ACTU | VRTX | Winner |
|---|---|---|---|
| Market Cap | $49.05M | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ACTU
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACTU or VRTX a better investment?
Comparing ACTU and VRTX: Actuate Therapeutics, Inc. Common stock has a market cap of $49.05M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACTU and VRTX?
ACTU (Actuate Therapeutics, Inc. Common stock) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACTU or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACTU or VRTX?
Both ACTU and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ACTU or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ACTU or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $49.05M for ACTU.
Should I buy ACTU or VRTX in 2026?
Both ACTU and VRTX have investment merit. ACTU trades at $N/A while VRTX trades at $485.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACTU and VRTX stock?
Key differences: Market Cap ($49.05M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ACTU or VRTX in 2026?
The choice between ACTU and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ACTU and VRTX?
ACTU (Actuate Therapeutics, Inc. Common stock) has a market cap of $49.05M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.